Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001415889-17-000683

Options or other derivatives

  • Director acquired 35,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
SAXE JON S Director 2017-04-26 Grant or award · Stock Option (Right to Buy) +35,000 35,000 D
Loading xslF345X03/form4-04282017_120442.xml…